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Abstract
Nucleic acids, especially extracellular RNA, are exposed following tissue- or vessel damage and have previously been shown
to activate the intrinsic blood coagulation pathway in vitro and in vivo. Yet, no information on structural requirements for
the procoagulant activity of nucleic acids is available. A comparison of linear and hairpin-forming RNA- and DNA-oligomers
revealed that all tested oligomers forming a stable hairpin structure were protected from degradation in human plasma. In
contrast to linear nucleic acids, hairpin forming compounds demonstrated highest procoagulant activities based on the
analysis of clotting time in human plasma and in a prekallikrein activation assay. Moreover, the procoagulant activities of the
DNA-oligomers correlated well with their binding affinity to high molecular weight kininogen, whereas the binding affinity
of all tested oligomers to prekallikrein was low. Furthermore, four DNA-aptamers directed against thrombin, activated
protein C, vascular endothelial growth factor and nucleolin as well as the naturally occurring small nucleolar RNA U6snRNA
were identified as effective cofactors for prekallikrein auto-activation. Together, we conclude that hairpin-forming nucleic
acids are most effective in promoting procoagulant activities, largely mediated by their specific binding to kininogen. Thus,
in vivo application of therapeutic nucleic acids like aptamers might have undesired prothrombotic or proinflammatory side
effects.
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Introduction
For a long time, the (patho-) physiological role of the intrinsic
pathway of blood coagulation remained unclear, largely because
the initiation of the ‘‘contact phase’’ activation was thought to
occur mainly via artificial surfaces such as kaolin or glass [1,2].
Although fibrillar collagens or heparin were proposed to serve as
natural promoters of contact phase activation (via factor XII
autoactivation) [3,4], recent studies from our and other laborato-
ries proposed that extracellular nucleic acids, or polyphosphates
and denatured proteins may serve as efficient cofactors in the onset
of intrinsic pathway activation under patho-physiological condi-
tions [5,6,7,8]. In particular, being an ‘‘alarm signal’’ under
conditions of tissue damage or vascular injury, extracellular
nucleic acids were proposed as ‘‘natural foreign surface’’ to
initiate factor XII autoactivation, resulting in enhanced thrombus
formation [5]. Several in vivo models confirmed the involvement of
extracellular RNA in arterial and venous thrombus formation,
edema formation and vascular hyperpermeability. Interestingly
enough, administration of ribonuclease 1 (RNase 1) significantly
reduced or prevented thrombus formation, stroke and develop-
ment of edema in respective animal models [5,9]. Under
conditions of activation of innate immunity with the formation
of neutrophil extracellular traps (NET), such DNA-histone
networks were shown to provide a procoagulant surface as well
[8].
Mechanistically, structure-function relationships that were
considered as determining factors for the procoagulant activity
of extracellular nucleic acids include: (a) the high negative charge
density of nucleic acids and (b) their polyanionic nature, required
for high affinity binding to the proteins of the contact phase
(including factors XII and XI, high molecular weight kininogen
and prekallikrein) [5]. In addition, (c) sufficiently long extracellular
RNA was found to promote protease activation in this system via a
‘‘template mechanism’’, by which both, the respective protease
and its protein substrate need to bind to the same RNA molecule,
which then may catalyse protease conversion [5,10]. Although
additional factors and conditions may contribute to the functional
activity of procoagulant nucleic acid molecules, a structure-based
analysis of their respective functions has not been undertaken so
far.
In the present study we provide first evidence that the secondary
structure of DNA and RNA oligonucleotides appears to be
important for their function as cofactors of the intrinsic
coagulation pathway in vitro. To this end, the influence of length,
secondary structure and sequence of such DNA- and RNA-
oligomers was assessed by functional coagulation assays. Further-
more, we addressed the question, whether artificial nucleic acids in
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form of DNA-aptamers, which recently provided promising results
as therapeutics for several diseases, were able to promote contact
phase activation. Additionally, we analyzed the procoagulant
activity of small nucleolar RNAs (snRNAs), which are released in
protein complexes during systemic lupus erythematosus (SLE), an
auto-immune disease with prevalent thrombotic side-effects
[11,12].
Our results indicate that small, double-stranded nucleic acid
compounds, including four DNA-aptamers and a snRNA, were
most effective to serve as promoters of intrinsic blood coagulation,
very likely through specific binding of the cofactor protein
kininogen.
Materials and Methods
Material
RNA-oligonucleotides were purchased from Purimex (Greben-
stein, Germany); biotinylated, unlabeled and hexaethylenglycol-
modified DNA-oligonucleotides were from Biomers (Ulm, Ger-
many). Sequences of the tested RNA and DNA constructs used in
this study are given in figure 1. Secondary structures of RNA- and
DNA-oligonucleotides were calculated by the mFold RNA and
mFold DNA database of the University of Albany (USA). Poly
(I:C) was purchased from InvivoGen (San Diego, USA). Chro-
mogenic substrate S2366, single-chain high molecular weight
kininogen and tissue plasminogen activator were from Haemo-
chrom Diagnostica (Essen, Germany); prekallikrein, factor XI and
factor XII were from American Diagnostica (Pfungstadt, Ger-
many). RNase, DNase, 26 RNA loading dye, 66DNA loading
dye and 100 bp DNA ladder and the restriction enzyme BamH1
with according reaction buffer were from Fermentas (St. Leon-
Rot, Germany). PureLink HiPure Plasma Midiprep Kit, Quant-
iTTM RNA assay kit and Qubit fluorometer were from Invitrogen
(Carlsbad, USA). DNA-plasmid and reagents for in vitro transcrip-
tion of U6snRNA were provided by Dr. Albrecht Bindereif
(Institute for Biochemistry, Justus-Liebig-University, Giessen,
Germany).
In vitro Transcription of U6snRNA
U6snRNA-containig DNA-plasmid was amplified and purified
by using the PureLink HiPure Plasma Midiprep Kit according to
the manufacturer’s instructions, followed by digestion with the
restriction enzyme BamH1 and purification via phenol/chloro-
form extraction. RNA-transcription of 1 mg BamH1-digested
DNA-plasmid was performed at 37uC for one hour by using
SP6 polymerase buffer, 10 mM dithiothreitol, 0.5 mM of the
ribonucleotides adenosine-, cytosine- and uracile-triphosphate as
well as 0.1 mM guanosine-triphospate, 20 units RNase Inhibitor
and 30 units of SP6-polymerase. Remaining DNA was digested by
incubation with 2 units of DNase at 37uC for 30 min. RNA was
isolated by phenol/chloroform extraction. The quality of the
RNA-transcript was confirmed by agarose gel electorphoresis
followed by staining in a 20% (v/v) ethidium bromide solution.
Concentration of RNA was measured with the Quant-iTTM RNA
assay kit and the Qubit fluorometer.
Plasma Preparation
Blood samples were obtained from the blood bank, University
Hospital, Giessen. All patients had to give a written consent,
approved by the Ethics Committee of the Medical Faculty, Justus-
Liebig-University, Giessen, file number 05/00. Data were
analyzed anonymously. Blood samples were centrifuged at
2,8006g at 4uC for 10 min to obtain platelet-poor plasma, pooled
and aliquots were frozen at 280uC until further use.
Polyacrylamide Gel Electrophoresis of RNA- and DNA-
oligonucleotides
Oligonucleotides were subjected to electrophoresis (1.25 mg/
lane) onto 20% (v/v) polyacrylamide gels and seperated using tris-
borate-EDTA buffer, followed by ethidium bromide staining. For
digestion experiments, 1.25 mg of the respective oligonucleotides
was incubated for 1 or 5 min at 37uC with 10 mL of pooled human
EDTA- plasma, followed by addition of 10 mL RNA loading dye
or 1.5 mL DNA loading dye and subsequent polyacrylamide gel
electrophoresis. Gels were stained in a 20% (v/v) ethidium
bromide solution.
Clot/lysis Assay in Human Plasma
A 96-well microtiter plate was blocked with 3% (w/v) bovine
serum albumin (BSA) in Tris-buffered saline (TBS) at 37uC for
1 h. All reagents to be added were dissolved in 0.1 M imidazol to a
final volume of 100 mL. Increasing concentrations of RNA- or
DNA-oligonucleotides were incubated with 100 ng/mL tissue
plasminogen activator (tPA). After addition of pooled EDTA-
plasma the plate was incubated for 5 min at 37uC. Following
addition of CaCl2 (200 nM) to start the reaction, clotting times,
defined as time points with maximal absorbance, were recorded
up to 30 min at 405 nm by using KC4 software (BIO-TEK, Bad
Friedrichshall, Germany).
Prekallikrein Acitivity Assay
A 96-well microtiter plate was blocked with 3% (w/v) BSA in
HEPES buffered saline (HBS) at 37uC for 1 h. All reagents were
dissolved in HBS to a final volume of 100 mL. Twenty nM
prekallikrein was incubated with 55 nM high molecular weight
kininogen, 0.3 mM chromogenic substrate S2366, 50 mM ZnCl2
and increasing concentrations of U6snRNA, poly (I:C) or artificial
RNA- and DNA-oligonucleotides, respectively. Prekallikrein (auto-
) activation was registered up to 60 min by cleavage of
chromogenic substrate S2366 and recorded at 405 nm by using
KC4 software (BIO-TEKs).
Binding of Nucleic Acids to Proteins
Biotinylated DNA-oligonucleotides were purchased from Bio-
mers (Ulm, Germany). Microtiter plate wells were coated with
50 mL solutions of prekallikrein, high molecular weight kininogen,
factor XI or factor XII (10 mg/mL each) in 100 mM sodium
carbonate (pH 9.5) at 4uC for 20 h. Wells coated with 100 mM
sodium carbonate (pH 9.5) only were used as blank for detection
of unspecific binding of biotinylated DNA-oligonucleotides. Wells
were washed and blocked with TBS containing 3% (w/v) BSA for
2 h. Different concentrations of biotinylated DNA-oligonucleo-
tides (0.31–50 mg/mL) were allowed to bind to adsorbed proteins
at 22uC for 2 h followed by three times washing with TBS. Bound
biotinylated nucleic acids were detected using peroxidase-conju-
gated streptavidin (Dako, Glostrup, Denmark) and the immuno-
pure TMB (3,39,5,59-tetramethylbenzidine) substrate kit (Pierce,
Rockford, USA) by quantitating the reaction products at 450 nm.
Statistics
Results were expressed as the mean 6 standard error of the
mean (SEM). Two-paired analysis of variance (ANOVA) and
subsequent multiple comparison using Bonferroni-post test were
used for statistical analysis. Results were considered as significant
at p,0.05.
Hairpin-Forming Nucleic Acids Promote Coagulation
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Figure 1. Sequences and secondary structures of DNA- and RNA-oligonucleotides. Described are the secondary structures of (A) DNA- and
(B) RNA-oligonucleotides as predicted by the mFold DNA or RNA database. Delta G (DG) values represent changes in free enthalpy representative for
the stability of the compounds with negative (exergonic) or positive values (endergonic).
doi:10.1371/journal.pone.0050399.g001
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Results
Stability of RNA- and DNA-oligonucleotides in Plasma
Cellular RNA and DNA have been demonstrated to serve as
cofactors for the initiation of the intrinsic pathway of coagulation
by promoting the auto-activation of the contact phase proenzymes
[5]. In order to gain insight into the structural features for their
mode of action, two oligonucleotides forming different secondary
structures (single-stranded, hairpin) were tested for their pro-
coagulant cofactor function in plasma and in purified systems
(Fig. 1). Firstly, the stability of these DNA- and RNA-oligonucle-
otides in human plasma was analyzed by polyacrylamide gel
electrophoresis. Pretreatment with human plasma for 1–5 min
revealed that all DNA-oligonucleotides remained largely stable,
while the 21mer-L1 RNA-oligonucleotide immediately disap-
peared, likely due to hydrolysis. The 21mer-H1 RNA-oligonucle-
otide was only partly degraded during the time of incubation, and
remained detectable even after 20 min (data not shown) due to
higher stability in human plasma compared to the linear RNA-
oligomer (Fig. 2A, 2B).
Procoagulant Activity of RNA- and DNA-oligonucleotides
In a plasma recalcification clotting assay different concentra-
tions of RNA- and DNA-oligonucleotides were tested for
procoagulant activity. Among the DNA- and RNA-oligonucleo-
tides, the 21mer-H1 was most effective to shorten the clotting time
in a dose-dependent manner to 60% or 75% of the control value,
respectively. The 21mer-L1-oligonucleotide promoted only a weak
procoagulant effect (Fig. 3A, 3B).
To investigate the influence of different oligonucleotides on a
typical protease activation step of the intrinsic coagulation
pathway, prekallikrein auto-activation (in the presence of kinino-
gen) was analysed. Among all RNA- and DNA-oligonucleotides,
the 21mer-H1 DNA compound exhibited the most impressive
cofactor activity in promoting prekallikrein auto-activation. No
cofactor activity was observed for both 21mer-L1-oligonucleotides
(Fig. 3C, 3D).
Functional Activities of Different DNA-hairpin Structures
As the 21mer-H1 DNA oligonucleotide revealed the highest
cofactor activity to promote coagulation, the procoagulant
functions of different single-stranded as well as hairpin-forming
DNA-oligonucleotides were compared (Fig. 1).
All tested single-stranded DNA-oligonucleotides revealed no or
only low effects in turbidity clot/lyis assays (Fig. 4B) or
prekallikrein activity tests (Fig. 4A). In contrast, the blunt-ended
21mer-H1 exhibited prominent cofactor activity in promoting the
auto-activation of prekallikrein, while 21mer-H2, which reveals a
39-overhang, was considerably less active. Moreover, 21mer-H3,
demonstrating a 59-overhang, had no cofactor activity (Fig. 4C).
All three compounds shortened the clotting time of human plasma
in a dose-dependent manner, whereby 21mer-H1 and 21mer-H2
showed most prominent effects (Fig. 4D). As demonstrated by
polyacrylamide gel electrophoresis, the DNA-oligonucleotides
21mer-H1 and 21mer-H2 represent single hairpin secondary
structures, while the majority of 21mer-H3 may form dimers
(Fig. 4E).
In order to corroborate these findings, binding assays using
biotinylated forms of two 21mer-DNA-hairpins as well as the
21mer-L1-molecule were performed. The oligonucleotide 21mer-
H1 revealed most efficient binding to kininogen with a dissociation
constant of KD= 1.82 mM (60.23) (Fig. 5A). All tested DNA-
oligomers only showed weak binding interactions to prekallikrein
(Fig. 5B). Furthermore, all tested oligomers exhibited low binding
to factor XII, while binding towards factor XI remained
undetectable (Fig. 5C). Functionality of the biotinylated oligonu-
cleotides was confirmed by prekallikrein activity assays (Fig. 5D).
Figure 2. Stability of DNA- and RNA-oligonucleotides in human plasma. (A) Integrity of 21mer-L1 and (B) 21mer-H1 DNA- and RNA-
oligonucleotides was confirmed by polyacrylamide gel electrophoresis without or after preincubation in pooled human plasma for 1 or 5 min,
respectively. Each panel represents one representative experiment out of three independent ones.
doi:10.1371/journal.pone.0050399.g002
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Contact Phase Activation by DNA-aptamers
Aptamers, exhibiting complex secondary structures, which
promote specific binding to target proteins, were analyzed for
their procoagulant functions. Therefore, four different apatmers
that are known as potent inhibitors of thrombin, activated protein
C (APC), vascular endothelial growth factor (VEGF) or nucleolin
(AS1411) were chosen (Fig. 1) [13,14,15,16]. All aptamers were
identified as efficient procoagulant cofactors by triggering the
auto-activation of prekallikrein, whereby the 15mer-thrombin
aptamer revealed the lowest effects (Fig. 6A). As the cofactor
activity of all tested aptamers decreased at higher concentrations, a
template mechanism is most likely. The functionality of the 15mer-
thrombin aptamer to inhibit thrombin formation in human plasma
was confirmed, as the clotting time was significantly prolonged or
completely impaired at high concentrations of the aptamer. In
contrast, all other tested aptamers promoted a significant
reduction of the clotting time (Fig. 6B).
As most aptamers with potential clinical relevance are
chemically modified to improve their stability in plasma, the
influence of one possible modification on the procoagulant
function of DNA-oligonucleotides was analyzed. Therefore a 59-
hexaethylenglycol was introduced to the 21mer-H1 DNA-oligo-
nucleotide and prekallikrein auto-activation was measured. No
significant difference was observed between the modified and the
unmodified compound. (Fig. 6C).
Procoagulant Activity of Small Nucleolar RNA (snRNA)
Spliceosomal protein-RNA complexes (small nuclear ribonu-
cleoprotein particles, snRNPs) serve as auto-antigens in several
auto-immune diseases like systemic lupus erythematosus (SLE),
which is often accompanied by thrombotic side-effects [11]. To
address the question, whether the protein-associated snRNA can
contribute to a procoagulant state, the influence of purified
U6snRNA (Fig. 7B) on prekallikrein auto-activation was deter-
mined. U6snRNA promoted the auto-activation of prekallikrein in
a concentration-dependent manner, which was comparable in its
degree to the artificial RNA-polymer poly (I:C) (Fig. 7A).
Discussion
Our study describes structural features of nucleic acids that are
required for promoting procoagulant cofactor function. Three
different aspects were identified to influence procoagulant
activities of small nucleotides in vitro: stability, secondary structure
and multimerisation. The analysis of stability of DNA- and RNA-
oligomers in human plasma demonstrated that all DNA-oligomers
remained largely intact confirming former studies which revealed
that DNA-oligomers are stable in plasma for up to two hours
independently of their structure [17]. In contrast, the decay rate of
RNA-oligomers, largely due to hydrolysis by RNases which are
present in human plasma [18,19], appeared to be dependent on
the secondary structure of the compounds. Accordingly, our
results demonstrate that linear RNA-structures are hydrolyzed
Figure 3. Procoagulant activity of DNA- and RNA-oligonucleotides with different length and secondary structures. Increasing
concentrations of (A) DNA-oligonucleotides 21mer-H1 (closed circles) or 21mer-L1 (closed squares) as well as (B) the respective RNA-oligonucleotides,
21mer-H1 (closed circles) or 21mer-L1 (closed squares) were tested for procoagulant activity in a turbidity clot-lysis assay using pooled human
plasma. Coagulation was initiated by recalcification; clotting times were defined as respective time points of maximal absorbance. The clotting time
of untreated plasma was defined as 100%. The activation of prekallikrein was followed in the presence of increasing doses of (C) DNA-
oligonucleotides 21mer-H1 (closed circles) or 21mer-L1 (closed squares) as well as (D) the respective RNA-oligonucleotides 21mer-H1 (closed circles)
or 21mer-L1 (closed squares). Enzyme activity was registered by chromogenic substrate assay as described in ‘‘Material and Methods’’. All data
represent mean 6 SEM (n$3; *p,0.05; 21mer-H1 vs. 21mer-L1).
doi:10.1371/journal.pone.0050399.g003
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immediately, while hairpin-forming compounds are more stable
and were detectable for up to 20 min in human plasma.
Moreover, a clear correlation was seen between secondary
structure-dependent stability of nucleic acid oligomers and
functional activity as procoagulant cofactors.
To further analyze the interactions between nucleic acid
oligomers and coagulation processes, the binding abilities of
different DNA-oligonucleotides to coagulation proteins were
compared. The data revealed that only the 21mer-H1 DNA
oligomer specifically interacted with high molecular weight
kininogen, whereas the other tested compounds presented low or
no binding to kininogen, prekallikrein, FXI or FXII. High
molecular weight kininogen is a multifunctional protein that
serves to accelerate the activation of FXII by kallikrein as well as
the activation of FXI [20,21,22] by forming non-covalent
equimolar complexes either with FXI [23,24] or with prekallikrein
in the presence of zinc ions [20,24,25,26]. Eighty percent of
prekallikrein is bound to kininogen in plasma, and this complex
may become associated with negatively charged surfaces (like
RNA or DNA) during contact phase activation [1,2,3,4]. Our
previous and present data indicate that contact phase activation is
mediated via a specific binding of hairpin-structured nucleic acid
oligomers to kininogen, mediating activation of prekallikrein and
FXI [5].
The present results extend the knowledge on differential
interactions of nucleic acids with the blood clotting cascade. Until
now, the roles of natural extracellular RNA and DNA as cofactors
for the (auto-) activation of serine proteases in the initiation of the
intrinsic coagulation pathway were mainly ascribed to charge-
dependent interactions. Based on the present results, nucleic acids
Figure 4. Procoagulant activity of different linear and hairpin-forming DNA-oligonucleotides. Increasing concentrations of the linear
DNA-oligonucleotides 21mer-L1 (closed squares), 21mer-L2 (closed triangels) or 21mer-L3 (closed circles) were analyzed for (A) prekallikrein auto-
activation or (B) procoagulant activity in a turbidity clot-lysis assay. The clotting time of untreated plasma was defined as 100%. All data represent
mean 6 SEM (n= 3). Increasing concentrations of the hairpin-forming DNA-oligonucleotides 21mer-H1 (closed circles), 21mer-H2 (open squares) or
21mer-H3 (open triangles) were analyzed for (C) prekallikrein auto-activation or (D) procoagulant activity in a turbidity clot-lysis assay. The clotting
time of untreated plasma was defined as 100%. All data represent mean 6 SEM (n$3; *p,0.05; 21mer-H1 vs. 21mer-H3; #p,0.05; 21mer-H2 vs.
21mer-H3). (E) The sizes of DNA-oligonucleotides were analyzed by polyacrylamide gel electrophoresis. Shown is one representative experiment out
of three independent ones.
doi:10.1371/journal.pone.0050399.g004
Hairpin-Forming Nucleic Acids Promote Coagulation
PLOS ONE | www.plosone.org 6 November 2012 | Volume 7 | Issue 11 | e50399
containing hairpin-forming structures provide potent procoagulant
functions. These structures are present in naturally occurring
RNA-macromolecules like ribosomal RNA, transfer-RNA and
messenger RNA, which are exposed/released from the cytoplasm
of damaged cells. Due to the presence of RNases in the circulation,
the half-life of such RNA-species may be limited and therefore a
systemic effect on activation of the clotting cascade would be
moderate. Nevertheless, local RNA concentrations at the site of
injury may be sufficient to trigger procoagulant effects.
Our study firstly identified a hairpin-containing, small nucleolar
RNA (U6snRNA; 107 nucleotides), which is part of the
spliceosome, as an efficient cofactor for the auto-activation of
prekallikrein. Several studies already described elevated plasma
levels of antibodies directed against snRNA-protein complexes
(snRNPs) [12,27] in patients suffering from SLE, an auto-immune
disease that is accompanied by thrombotic side-effects with a
prevalence of more than 10% (for review see [11]). Our results
indicate that snRNAs, likely to be released due to abnormal
apoptotic processes during SLE (for review see [28]), could
contribute to this prothrombotic state already at very low
concentrations. This effect was comparable to the activity of the
artificial RNA-polymer poly (I:C), which has no defined secondary
structure and promotes coagulation most likely via charge-
dependent interactions due to its polyanionic character.
In vivo models of thrombosis and stroke revealed that
pretreatment with RNase but not with DNase completely
abolished procoagulant activities of extracellular RNA [5,9]. This
indicates that the physiological role of cellular DNA for activation
of the clotting cascade under conditions of tissue damage is low,
possibly due to its buried position within the nucleus and its
association with histones [5,9]. Additional studies of Oehmcke
et al. identified extracellular DNA released by neutrophils under
inflammatory conditions in form of neutrophil extracellular traps
(NET) as physiologically relevant inducer of the intrinsic
coagulation pathway [8]. This NET-forming DNA reveals stable
secondary structures [29], which could, beside charge-dependent
interactions, represent possible binding sites for serine proteases.
Our observations that hairpin-forming DNA-oligomers were
most potent activators of the intrinsic coagulation pathway may
also have clinical relevance, since activation of blood coagulation
might be a potential side effect during the application of various
DNA- or RNA-aptamers. First indications that DNA-aptamers
have a procoagulant potential were presented in a study from Paul
et al. in 2010, whereby DNA-aptamer libraries, which represent a
Figure 5. Binding of biotinylated DNA-oligonucleotides to different coagulation factors of the intrinsic coagulation pathway.
Microtiter plate wells were coated with 10 mg/mL each of (A) kininogen or (B) prekallikrein and binding of increasing concentrations of the
biotinylated DNA-oligonucleotides 21mer-H1 (closed circles), 21mer-H3 (open triangles), 21mer-L1 (closed squares) was assessed. All data represent
mean 6 SD (n = 3; *p,0.05; 21mer-L1 and 21mer-H3 vs. 21mer-H1) of one representative experiment out of three independent ones. (C) Microtiter
plate wells were coated with 10 mg/mL kininogen, factor XI (FXI) or factor XII (FXII) each and incubated with 25 mg/mL each of different biotinylated
DNA-oligonucleotides: 21mer-H1 (black bars), 21mer-H3 (white bars) or 21mer-L (hatched bars). All data represent mean 6 SD (n = 3) of one
representative experiment out of three independent ones. (D) Increasing concentrations of the biotinylated DNA-oligonucleotides 21mer-H1 (closed
circles), 21mer-H3 (open triangles) or 21mer-L1 (closed squares) were analyzed for prekallikrein auto-activation. All data represent mean6 SEM (n$3;
*p,0.05; 21mer-H1 vs. 21mer-H3).
doi:10.1371/journal.pone.0050399.g005
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Figure 6. Influences of DNA-aptamers on the intrinsic coagulation pathway. (A) The activation of prekallikrein was followed in the presence
of increasing doses of the DNA-aptamers 15mer-thrombin (open circles, interrupted line), 44mer-APC (closed squares), 26mer-AS1411 (closed circles)
or 25mer-VEGF (closed triangles, dotted line). (B) Turbidity clot-lysis assays were performed in the absence (black bars) or presence of 1.25 mg/mL
(white bars) and 10 mg/mL (striped bars) of the DNA-aptamers 15mer-thrombin, 44mer-APC, 26mer-AS1411 or 25mer-VEGF, respectively. Coagulation
was initiated by recalcification, clotting times were defined as respective time points of maximal absorbance. The clotting time of untreated plasma
was defined as 100%. All data represent mean 6 SEM (n = 3; *p,0.05; 1.25 mg/mL or 10 mg/mL vs. control). (C) The activation of prekallikrein was
followed in the presence of increasing doses of the oligonucleotide 21mer-H1 (closed circles) and 21mer-H1-HEG (closed squares). All data represent
mean 6 SEM (n= 6).
doi:10.1371/journal.pone.0050399.g006
Figure 7. Procoagulant activity of snRNAs. (A) Increasing concentrations of U6snRNA (closed triangles, black line) or poly (I:C) (closed diamonds,
dotted line) were analyzed for prekallikrein auto-activation. All data represent mean 6 SEM (n= 3). (B) Integrity of U6snRNA was confirmed by
agarose gelelectrophoresis.
doi:10.1371/journal.pone.0050399.g007
Hairpin-Forming Nucleic Acids Promote Coagulation
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mixture of DNA molecules with random sequences and secondary
structures, were shown to activate the contact phase protein
prekallikrein in an in vitro Chandler-Loop-model [30]. Their study,
however, did not approach the question, whether all molecules of
the library were able to provide cofactor functions or if only
aptamers with certain characteristics were responsible for the
described effects.
To address this question, the procoagulant functions of four
DNA-aptamers against thrombin (determined to be anti-coagu-
lant) [13], APC (determined to inhibit the anti-coagulant function
of APC) [14], VEGF (binding to VEGF) [16] and AS1411
(inhibiting nucleolin function for cancer therapy) [15] were
analyzed at concentrations comparable to plasma levels achieved
during different clinical studies [31,32,33]. All aptamers revealed
appreciable procoagulant cofactor function concerning the auto-
activation of prekallikrein. Referring to the results discussed above,
especially the already described quadruplex-structure of the
thombin-aptamer, the AS1411-aptamer [15,34], the probable
quadruplex structure (due to high GC-content) of the VEGF-
aptamer as well as the hairpin-containing sequences of the APC-
aptamer should be considered as procoagulant domains.
Additionally, all aptamers except the thombin-aptamer reduced
the clotting time of human plasma significantly, underlining their
direct procoagulant function. As the significant increase in clotting
time in human plasma confirmed the functionality of the
thrombin-aptamer due to efficient inhibition of clot formation,
no thrombotic side effects are expected by a systemic application
of this compound. However, due to the activation of prekallikrein
and the related release of bradykinin from kininogen, all tested
aptamers could induce vasodilation or proinflammatory effects,
which should be investigated by further studies. Preliminary
experiments indicated a VEGF-mediated induction of endothelial
hyperpermeability by different DNA-oligomers, which was inde-
pendent of their secondary structure (data not shown). This effect
was comparable to the already described RNA-induced hyper-
permeability [9].
Furthermore, it has to be mentioned that the DNA-aptamers
used for this study were not chemically modified. In contrast, most
of the aptamers developed for therapeutical issues may carry
several modifications including 59-polyethylenglycol, 29-fluoro-, 29-
aminomethyl- or 29-O-methyl groups [35,36,37] to increase their
stability in plasma. These modifications could modulate the here
identified procoagulant activities of aptamers. To address this
question, the procoagulant activity of the unmodified 21mer-H1
oligonucleotide was compared with a 21mer-H1 construct
carrying a 59-hexaethylenglycol modification. Both compounds
revealed comparable promotion of auto-activation of prekallikrein,
indicating that a 59-hexaethylenglycol modification is not influ-
encing the procoagulant activity of this DNA-olionucleotide.
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